The launch of a new generic drug by ANI Pharmaceuticals is likely to have a positive impact on the company's revenue, given the size of the existing market for the branded version. As the company captures market share, this could lead to increased sales and potentially a positive reaction in the stock price in the short term. The confidence in this analysis is high due to the specific mention of the market size and the direct relation of the product launch to ANI Pharmaceuticals' business.